OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
https://www.zacks.com/stock/news/2245547/opko-health-opk-and-entera-bio-announce-data-for-glp-2?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245547
Mar 25, 2024 - OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
0
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2238787/takeda-pharmaceutical-co-tak-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2238787
Mar 11, 2024 - Takeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
https://www.zacks.com/stock/news/2238576/are-investors-undervaluing-takeda-pharmaceutical-co-tak-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2238576
Mar 11, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript
https://seekingalpha.com/article/4667172-takeda-pharmaceutical-company-limited-tak-q3-2023-earnings-call-transcript?source=feed_tag_japan
Feb 02, 2024 - Takeda Pharmaceutical Company Limited (NYSE:NYSE:TAK) Q3 2023 Earnings Conference Call February 1, 2024 8:00 AM ETCompany ParticipantsChristopher O’Reilly –...
0
Pages: 1
Page 1